MedPath

VABOMERE

VABOMERE

Approved
DIN Number

02554151

Drug Class

Human

Market Date

N/A

Company
HC

xediton pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02554151
AIG Number0266424001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01DH52 MEROPENEM AND VABORBACTAM
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification08:12.07.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

MEROPENEM (MEROPENEM TRIHYDRATE)Active
Strength: 1 G / VIAL
Monograph: MEROPENEM (MEROPENEM TRIHYDRATE)
VABORBACTAMActive
Strength: 1 G / VIAL
Monograph: VABORBACTAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.